HIGHLIGHTS   |  November 21, 2019   FDA Approves Zanubrutinib to Treat Mantle Cell Lymphoma The FDA granted accelerated approval to zanubrutinib (Brukinsa) capsules for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least 1 prior therapy, according to the agency. Read more     Marjorie Zauderer, MD, on New Immunotherapy Approaches Marjorie Zauderer, MD, from Memorial Sloan Kettering Cancer Center, discussed new immunotherapy approaches at SITC 2019. Read more IN CASE YOU MISSED IT   Patient-Reported Outcomes Bolster Breast Cancer Treatment New findings show that patient-reported outcome measures (PROMs) could be of most benefit if standardized across healthcare Read more